Eva Hellmis
Impact in
- Biochemistry top 10%
- Antioxidant Activity and Oxidative Stress
- Phytochemicals and Antioxidant Activities
- Urology top 10%
- Urinary Bladder and Prostate Research
Papers in
-
- Prostate Cancer Treatment and Research 9
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- PARP inhibition in cancer therapy 2
- Co-authors
- Silke Schwarz (1 shared paper)Hans Konrad Biesalski (1 shared paper)G. H. Jacobi (1 shared paper)Ute C. Obermüller-Jevic (1 shared paper)Boris Hadaschik (2 shared papers)Stefan Siemer (2 shared papers)S. Alloussi (2 shared papers)H. Madersbacher (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)European Journal of Cancer (1 paper)British Journal of Urology (1 paper)BMC Cancer (1 paper)Journal of Nutrition (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Eva Hellmis
15 papers receiving 194 citations
Peers
Comparison fields: 5 of 56
- Biochemistry 57
- Urology 56
- Rheumatology 35
- Endocrinology, Diabetes and Metabolism 25
- Pediatrics, Perinatology and Child Health 28
Countries citing papers authored by Eva Hellmis
This map shows the geographic impact of Eva Hellmis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hellmis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hellmis more than expected).
Fields of papers citing papers by Eva Hellmis
This network shows the impact of papers produced by Eva Hellmis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hellmis. The network helps show where Eva Hellmis may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Hellmis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 107 | |
| 2 | 2009 | 41 | |
| 3 | 2008 | 22 | |
| 4 | 2024 | 9 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 3 | |
| 8 | 2019 | 2 | |
| 9 | 2020 | 2 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2006 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2025 | 0 |
About Eva Hellmis
Eva Hellmis is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 201 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Lipids, and Metabolism (2 papers), Hormonal and reproductive studies (2 papers), Urinary Bladder and Prostate Research (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Biochemistry (57 citations), Urology (56 citations), Rheumatology (35 citations), Endocrinology, Diabetes and Metabolism (25 citations) and Pediatrics, Perinatology and Child Health (28 citations). Eva Hellmis has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Silke Schwarz, Hans Konrad Biesalski, G. H. Jacobi, Ute C. Obermüller-Jevic, Boris Hadaschik, Stefan Siemer, S. Alloussi, H. Madersbacher, Werner Horn and Gerd Mürtz. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Urology, BMC Cancer and Journal of Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.